Buzzetti E, Pinzani M, Tsochatziz EA. The multiple-hit pathogensesis of non-alcoholic fatty liver disease (NAFLD). Metabolism. 2016;65:1038–48.

PubMed  CAS  Google Scholar 

Eslam M, Newsome PN, Sarin SK, et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol. 2020;73:202–9.

PubMed  Google Scholar 

Estes C, Razavi H, Loomba R, Younossi Z, Sanyal AJ. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. Hepatology. 2018;67:123–3.

PubMed  CAS  Google Scholar 

Cotter TG, Charlton M. Nonalcoholic steatohepatitis after liver transplantation. Liver Transpl. 2020;26:141–59.

PubMed  Google Scholar 

Madsbad S, Dirksen C, Holst JJ. Mechanisms of changes in glucose metabolism and body weight after bariatric surgery. Lancet Diabetes Endocrinol. 2014;2:152–64.

PubMed  CAS  Google Scholar 

Maciejewski ML, Arterburn DE, Van Scoyoc L, et al. Bariatric surgery and long-term durability of weight loss. JAMA Surg. 2016;151:1046–55.

PubMed  PubMed Central  Google Scholar 

Wong V. Current prevention and treatment options for NAFLD. Adv Exp Med Biol. 2018;1061:149–57.

PubMed  CAS  Google Scholar 

Stahl JM, Malhotra S. Obesity Surgery Indications and Contraindications. 2023. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.

Flack JM, Adekola B. Blood pressure and the new ACC/AHA hypertension guidelines. Trends Cardiovasc Med. 2020;30:160–4.

PubMed  Google Scholar 

Weir CB, Jan A. BMI Classification Percentile And Cut Off Points. 2023. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.

Chakraborty S, Ganie MA, Masoodi I, et al. Fibroscan as a non-invasive predictor of hepatic steatosis in women with polycystic ovary syndrome. Indian J Med Res. 2020;151:333–4.

PubMed  PubMed Central  CAS  Google Scholar 

Lin ZH, Xin YN, Dong QJ, et al. Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis. Hepatology. 2011;53:726–36.

PubMed  Google Scholar 

Lee J, Vali Y, Boursier J, et al. Prognostic accuracy of FIB-4, NAFLD fibrosis score and APRI for NAFLD-related events: a systematic review. Liver Int. 2021;41:261–70.

PubMed  PubMed Central  Google Scholar 

Treeprasertsuk S, Björnsson E, Enders F, Suwanwalaikorn S, Lindor KD. NAFLD fibrosis score: a prognostic predictor for mortality and liver complications among NAFLD patients. World J Gastroenterol. 2013;19:1219–29.

PubMed  PubMed Central  Google Scholar 

Zibaeenejad F, Mohammadi SS, Sayadi M, Safari F, Zibaeenezhad MJ. Ten-year atherosclerosis cardiovascular disease (ASCVD) risk score and its components among an Iranian population: a cohort-based cross-sectional study. BMC Cardiovasc Disord. 2022;22:162.

PubMed  PubMed Central  Google Scholar 

Soares G, Soares Monteiro LB. Ultrasound-based techniques for the diagnosis of liver steatosis. World J Gastroenterol. 2019;25:6053–62.

Google Scholar 

Shalimar, Kumar R, Rout G, et al. Body mass index–based controlled attenuation parameter cut-offs for assessment of hepatic steatosis in non-alcoholic fatty liver disease. Indian J Gastroenterol. 2020;39:32–41.

Lin YS. Ultrasound evaluation of liver fibrosis. J Med Ultrasound. 2017;25:127–9.

PubMed  PubMed Central  Google Scholar 

Zundel N, Hernandez RJD, Gagner M. Laparoscopic sleeve gastrectomy: technique and outcomes. The ASMBS Textbook of Bariatric Surgery. 2020. pp. 149–59.

Barbois S, Stürm N, Aron-Wisnewsky J, et al. Decision tree for the performance of intraoperative liver biopsy during bariatric surgery. Obes Surg. 2021;31:2641–8.

PubMed  Google Scholar 

Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41:1313–21.

PubMed  Google Scholar 

Lin S, Huang J, Wang M, et al. Comparison of MAFLD and NAFLD diagnostic criteria in real world. Liver Int. 2020;40:2082–9.

PubMed  Google Scholar 

Nedeljkovic-Arsenovic O, Banovic M, Radenkovic D, et al. The amount of weight loss six months after bariatric surgery: it makes a difference. Obes Facts. 2019;12:281–90.

PubMed  PubMed Central  Google Scholar 

Risi R, Rossini G, Tozzi R, et al. Sex difference in the safety and efficacy of bariatric procedures: a systematic review and meta-analysis. Surg Obes Relat Dis. 2022;18:983–96.

PubMed  Google Scholar 

Attia D, Abdel Alem S, El-Akel W, et al. Prevalence and clinical characteristics of patients with metabolic dysfunction-associated fatty liver disease with hepatitis C virus infection—a population-based study. Aliment Pharmacol Ther. 2022;56:1581–90.

PubMed  CAS  Google Scholar 

Liu CJ, Seto WK, Yu ML. Dual-etiology MAFLD: the interactions between viral hepatitis B, viral hepatitis C, alcohol, and MAFLD. Hep Intl. 2024;18 Suppl 2:897–908.

Soroceanu RP, Timofte DV, Maxim M, et al. Twelve-month outcomes in patients with obesity following bariatric surgery—A single centre experience. Nutrients. 2023;15:1134.

PubMed  PubMed Central  CAS  Google Scholar 

Iannelli A, Treacy P, Sebastianelli L, Schiavo L, Martini F. Perioperative complications of sleeve gastrectomy: review of the literature. J Minim Access Surg. 2019;15:1–7.

PubMed  PubMed Central  Google Scholar 

Harrison SA, Gawrieh S, Roberts K, et al. Prospective evaluation of the prevalence of non-alcoholic fatty liver disease and steatohepatitis in a large middle-aged US cohort. J Hepatol. 2021;75:284–91.

PubMed  Google Scholar 

Machado M, Marques-Vidal P, Cortez-Pinto H. Hepatic histology in obese patients undergoing bariatric surgery. J Hepatol. 2006;45:600–6.

PubMed  Google Scholar 

Younossi ZM. The epidemiology of nonalcoholic steatohepatitis. Clin Liver Dis. 2018;11:92–4.

Google Scholar 

Nikai H, Ishida K, Umemura A, et al. Effects of laparoscopic sleeve gastrectomy on non-alcoholic steatohepatitis and liver fibrosis in Japanese patients with severe obesity. Obes Surg. 2020;30:2579–87.

PubMed  Google Scholar 

Manco M, Mosca A, De Peppo F, et al. The benefit of sleeve gastrectomy in obese adolescents on nonalcoholic steatohepatitis and hepatic fibrosis. J Pediatr. 2017;180:31-7.e2.

Keleidari B, Mahmoudie M, Anaraki AG, et al. Six month-follow up of laparoscopic sleeve gastrectomy. Adv Biomed Res. 2016;5:49.

PubMed  PubMed Central  Google Scholar 

Weiss R, Appelbaum L, Schweiger C, et al. Short-term dynamics and metabolic impact of abdominal fat depots after bariatric surgery. Diabetes Care. 2009;32:1910–5.

PubMed  PubMed Central  Google Scholar 

Zadeh-Vakili A, Tehrani FR, Hosseinpanah F. Waist circumference and insulin resistance: a community based cross sectional study on reproductive aged Iranian women. Diabetol Metab Syndr. 2011;3:18.

PubMed  PubMed Central  Google Scholar 

Kathak RR, Sumon AH, Molla NH, et al. The association between elevated lipid profile and liver enzymes: a study on Bangladeshi adults. Sci Rep. 2022;12:1711.

PubMed  PubMed Central  CAS  Google Scholar 

Benaiges D, Flores-Le-Roux JA, Pedro-Botet J, et al. Impact of restrictive (sleeve gastrectomy) vs hybrid bariatric surgery (Roux-en-Y gastric bypass) on lipid profile. Obes Surg. 2012;22:1268–75.

PubMed  CAS  Google Scholar 

Griffo E, Cotugno M, Nosso G, et al. Effects of sleeve gastrectomy and gastric bypass on postprandial lipid profile in obese type 2 diabetic patients: a 2-year follow-up. Obes Surg. 2016;26:1247–53.

PubMed  CAS  Google Scholar 

Kim KH, Kim Y, Seo KI, Seo KW. Short-term outcome of bariatric surgery on nonalcoholic fatty liver disease: a Korean perspective. Ann Surg Treat Res. 2022;102:353–9.

PubMed  PubMed Central  CAS  Google Scholar 

Seeberg KA, Borgeraas H, Hofsø D, et al. Gastric bypass versus sleeve gastrectomy in type 2 diabetes: effects on hepatic steatosis and fibrosis: a randomized controlled trial. Ann Intern Med. 2022;175:74–83.

PubMed  Google Scholar 

English WJ, Spann MD, Aher CV, Williams DB. Cardiovascular risk reduction following metabolic and bariatric surgery. Ann Transl Med. 2020;8 Suppl 1:S12.

Yoo JJ, Kim W, Kim MY, et al. Recent research trends and updates on nonalcoholic fatty liver disease. Clin Mol Hepatol. 2019;25:1–11.

PubMed  Google Scholar 

Yang R, Gui X, Ke H, Yu X, Yan Y, Xiong Y. Accuracy of FIB-4 and APRI scores compared to transient elastography for liver fibrosis in patients with HIV and HBV co-infection. Int J STD AIDS. 2023;34:18–24.

PubMed  Google Scholar 

Papadopoulos N, Vasileiadi S, Papavdi M, et al. Liver fibrosis staging with combination of APRI and FIB-4 scoring systems in chronic hepatitis C as an alternative to transient elastography. Ann Gastroenterol. 2019;32:498–503.

PubMed  PubMed Central  Google Scholar 

Alexopoulos AS, Crowley MJ, Wang Y, et al. Glycemic control predicts severity of hepatocyte ballooning and hepatic fibrosis in nonalcoholic fatty liver disease. Hepatology. 2021;74:1220–33.

PubMed  CAS  Google Scholar 

Masroor M, Haque Z. HbA1C as a biomarker of non-alcoholic fatty liver disease: comparison with anthropometric parameters. J Clin Transl Hepatol. 2021;9:15–21.

PubMed